NCT/Study#

NCT04458259 /

C4201002

A Phase 1, Open-Label, Multi-Center, Dose-Finding, Pharmacokinetic, Safety And Tolerability Study Of PF-07265807 In Participants With Selected Advanced Or Metastatic Solid Tumor Malignancies

A Phase 1, Open-Label, Multi-Center, Dose-Finding, Pharmacokinetic, Safety And Tolerability Study Of PF-07265807 In Participants With Selected Advanced Or Metastatic Solid Tumor Malignancies

DISEASE GROUP:
Phase 1
current phase:
Phase I
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: